What's in Ming-Yuan Chen's pipeline?

Ming-Yuan Chen has 4 drugs in our index: 0 marketed, 0 filed, 3 in Phase 3, 0 in Phase 2, 1 in Phase 1.

Which companies overlap with Ming-Yuan Chen's portfolio?

Top competitors by shared drug class: Bristol-Myers Squibb, Sun Yat-sen University, Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University, ATGC Co., Ltd., Akeso.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/ming-yuan-chen.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-06-10 · How we verify

Ming-Yuan Chen — Portfolio Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Ming-Yuan Chen pipeline: 0 marketed, 0 filed, 3 Phase 3, 0 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

0 marketed 0 filed 3 Phase 3 0 Phase 2 1 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area
Cisplatin-based induction chemotherapy	Cisplatin-based induction chemotherapy	phase 3	Platinum-based alkylating agent	DNA	Oncology
Full course of PD-1blockades	Full course of PD-1blockades	phase 3	PD-1 inhibitor	PD-1	Oncology
Full course of PD-1 monoclonal antibody	Full course of PD-1 monoclonal antibody	phase 3	PD-1 inhibitor	PD-1	Oncology

Therapeutic area mix

Oncology · 3

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

Bristol-Myers Squibb · 2 shared drug classes
Sun Yat-sen University · 2 shared drug classes
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University · 2 shared drug classes
ATGC Co., Ltd. · 1 shared drug class
Akeso · 1 shared drug class
Amgen · 1 shared drug class
Ahn-Gook Pharmaceuticals Co.,Ltd · 1 shared drug class
Asahi Kasei Pharma Corporation · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Ming-Yuan Chen:

Cite this brief

Drug Landscape (2026). Ming-Yuan Chen — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/ming-yuan-chen. Accessed 2026-06-10.